Vimarsana
Biggest News Aggregation in the World

Microcap Fraud Task Force News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Microcap Fraud Task Force. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Microcap Fraud Task Force Today - Breaking & Trending Today

SEC Announces Enforcement Task Force Focused on Climate and ESG Issues | Ballard Spahr LLP - Vimarsana News

SEC Announces Enforcement Task Force Focused on Climate and ESG Issues | Ballard Spahr LLP

To embed, copy and paste the code into your website or blog: Today, the SEC sent a very clear signal about one of its chief enforcement priorities by  announcing the creation of a Climate and ESG Task Force within the Division of Enforcement. ESG stands for Environmental, Social, and Governance. Since Allison Herren Lee was named the Acting Chair of the SEC on January 21, 2021, the SEC has repeatedly signaled that Climate and ESG issues and disclosures will be an SEC priority. For instance, on February 1, 2021, the SEC  announced that Acting Chair Lee would have, for the first time, a sen...

SEC Charges Biotech Company and CEO with Fraud Concerning COVID-19 Blood Testing Device - Vimarsana News

SEC Charges Biotech Company and CEO with Fraud Concerning COVID-19 Blood Testing Device

SEC Charges Biotech Company and CEO with Fraud Concerning COVID-19 Blood Testing Device Washington, D.C.--(Newsfile Corp. - December 18, 2020) - The Securities and Exchange Commission today announced charges against California-based biotechnology company Decision Diagnostics Corp. and its CEO, Keith Berman, with making false and misleading claims in numerous press releases that the company had developed a working, break-through technology that could accurately detect Covid-19 through a quick blood test. The SEC temporarily suspended trading in Decision Diagnostics' securities on April 23, 20...

SEC.gov | SEC Charges Biotech Company and CEO With Fraud Concerning COVID-19 Blood Testing Device - Vimarsana News

SEC.gov | SEC Charges Biotech Company and CEO With Fraud Concerning COVID-19 Blood Testing Device

FOR IMMEDIATE RELEASE Washington D.C., Dec. 18, 2020 — The Securities and Exchange Commission today announced charges against California-based biotechnology company Decision Diagnostics Corp. and its CEO, Keith Berman, with making false and misleading claims in numerous press releases that the company had developed a working, break-through technology that could accurately detect Covid-19 through a quick blood test. The SEC temporarily suspended trading in Decision Diagnostics' securities on April 23, 2020. The SEC's complaint alleges that Decision Diagnostics and Berman ...

Source: sec.gov